Search for dissertations about: "CYP2C8"
Showing result 1 - 5 of 8 swedish dissertations containing the word CYP2C8.
-
1. Pharmacogenetic Studies of Paclitaxel in Ovarian Cancer : focus on interindividual differences in pharmacodynamics and pharmacokinetics
Abstract : Ovarian cancer is one of the most common female cancer diseases in the world today and in Sweden more than 800 new cases are diagnosed every year. The standard treatment consists of chemotherapy with paclitaxel in combination with carboplatin after initial cytoreductive surgery. READ MORE
-
2. Genetic polymorphisms in breast cancer in relation to risk and prognosis
Abstract : Breast cancer is the most common cancer in women living in Sweden and the second most common cancer in the rest of the world. The risk of developing breast cancer is modified by environment, lifestyle, genetics and a combination of these factors. READ MORE
-
3. Integration of Tumor and Host Factors – Implications for Breast Cancer Prognosis
Abstract : Breast cancer is the most common cancer among women worldwide, although the mortality rates have decreased in the last decades. Breast cancer is a heterogeneous disease, and treatment resistance is a significant clinical problem in spite of the overall high survival rates. READ MORE
-
4. Interindividual variation in drug metabolism with focus on polymorphic cytochrome P450 2C9
Abstract : Cytochromes P450 (CYP) are enzymes, mainly catalysing the oxidation of xenobiotics, in order to facilitate their excretion from the body. CYP2C9 is a polymorphic enzyme, which is responsible for the metabolism of about 10 % of all known drugs, e. READ MORE
-
5. Cytochrome P450 pharmacogenetics : implications for anticancer and warfarin therapy
Abstract : There is a pronounced interindividual variability in the drug disposition, response and toxicity. Pharmacogenetics aims at identifying genetic biomarkers that could help to increase the drug efficacy, reduce adverse drug reactions and contribute to the development of personalized medicine. READ MORE